• Omeprazole A2845: Practical Research Workflow

  2026-08-30

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for gastric acid secretion research and functional acid-formation assays. Its water and ethanol insolubility, DMSO solubility, storage requirements, and research-use-only status must be addressed before use in antiulcer activity studies or peptic ulcer disease models.

• Thioguanine: From Mechanism to Translation

  2026-08-29

  Thioguanine, also known as 6-thioguanine, is more than a legacy thiopurine immunosuppressant. This thought-leadership analysis connects HGPRT- and DNMT1-associated biology with cancer cell proliferation inhibition, inflammatory bowel disease treatment, and emerging EV71 virus inhibition, while defining practical validation steps for translational researchers.

• Ibotenic Acid: From Lesions to Circuit Logic

  2026-08-28

  Ibotenic acid is an NMDA receptor agonist that can reveal how local glutamatergic perturbation reshapes neural function. This guide connects its experimental use with a brain-to-spinal pain circuit study to improve model selection, controls, and interpretation.

• Polyethylenimine Linear: Astrocyte Assays

  2026-08-28

  Build reproducible plasmid-delivery workflows with Polyethylenimine Linear, PEI MW 40,000, from 96-well optimization to mechanistic astrocyte studies. The approach connects serum-compatible transient expression with practical controls for investigating the H3K18la–NOD2 pathway implicated in bilirubin-induced pyroptosis.

• IPR-803: Reframing uPAR Blockade for Translation

  2026-08-27

  IPR-803 offers a mechanistically defined way to interrogate uPAR–uPA signaling in invasion, metastasis, angiogenesis, and stromal remodeling. This thought-leadership analysis connects breast cancer metastasis data with pancreatic cancer nanomedicine, while separating validated evidence from translational hypotheses.

• Aztreonam as a Phenotypic Probe in CREC Research

  2026-08-27

  Aztreonam offers a focused way to connect Gram-negative antibacterial phenotypes with the plasmid and chromosome biology of carbapenem-resistant Enterobacter cloacae. This article translates recent Guangdong surveillance findings into practical assay-design decisions while addressing compound handling and mammalian research endpoints.

• Amplex Red C4839: Reliable ROS Assays

  2026-08-26

  Learn how Amplex Red (SKU C4839) can strengthen hydrogen peroxide and reactive oxygen species measurements alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers assay compatibility, NAD(P)H interference, protocol parameters, interpretation, and practical product selection.

• TRPV1 Modulation in Metastatic Breast Cancer

  2026-08-26

  This 2021 study shows that TRPV1 modulation produces opposite cytokine outcomes in immune cells from healthy versus metastatic breast carcinoma-bearing mice. Its central practical implication is that TRPV1 agonists may require context-sensitive dosing because tumor-associated immune activation can increase IL-6 while suppressing IFN-γ.

• MK-2206 Dihydrochloride: Akt Assay Workflow

  2026-08-25

  Build cleaner Akt-pathway experiments with MK-2206 dihydrochloride, from dose-response and apoptosis assays to mechanistic validation. This workflow also translates a new Bordetella host-signaling finding into a practical strategy for testing Akt dependence without overstating what the infection study proves.

• L-NAME Hydrochloride in NO Pathway Workflows

  2026-08-25

  L-NAME Hydrochloride provides a practical chemical control for separating nitric oxide synthase activity from broader inflammatory signaling. This workflow-focused guide connects cellular NO assays with vascular tone regulation studies, hypertension research, and cardiovascular disease model design while highlighting controls, dosing logic, and troubleshooting.

• AZD1480 and the Hidden JAK2/STAT3 Escape Route

  2026-08-24

  IDO1 blockade can activate antitumor immunity while simultaneously inducing IL-6-driven, tumor-intrinsic JAK2/STAT3 survival signaling. This article positions AZD1480 as a mechanistically focused research tool for separating immune activation from adaptive tumor protection and for designing more informative translational studies.

• AC008406.3, Cuproptosis, and Docetaxel Sensitivity

  2026-08-24

  A 2026 study identifies the lncRNA AC008406.3 as a suppressor of cuproptosis and a determinant of docetaxel sensitivity in breast cancer cells. Its integrated transcriptomic and experimental design links AC008406.3 inhibition with copper accumulation, loss of lipoylated and Fe–S cluster proteins, and stronger docetaxel-associated tumor suppression.

• Angiotensin III: A Smarter RAAS Assay Strategy

  2026-08-23

  Angiotensin III is more than a downstream RAAS fragment: its sequence, receptor profile, and emerging spike-binding effects can reshape assay design. This guide connects peptide identity and preanalytical control with cardiovascular, neuroendocrine, and carefully bounded cross-domain research applications.

• REV1-DHX36 Coordination at G-Quadruplex Forks

  2026-08-22

  A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding with suppression of replication-associated single-stranded DNA gaps. The findings define a two-tiered mechanism for G4 tolerance and clarify how REV1 loss reshapes fork progression, mutagenesis, and ATM/ATR signaling.

• Tomivosertib: From MNK Biology to AML Assays

  2026-08-22

  Tomivosertib is a selective MNK1 inhibitor that enables researchers to connect eIF4E phosphorylation with leukemic-cell phenotypes. This article presents a mechanistic assay framework for separating target engagement, translational control, and downstream AML responses.

7787 records 1/520 page Next 12345 下5页 Last page